schliessen

Filtern

 

Bibliotheken

Promoter Hypermethylation Mediated Downregulation of FBP1 in Human Hepatocellular Carcinoma and Colon Cancer (FBP1 Promoter Methylation in HCC and Colon Cancer)

FBP1, fructose-1,6-bisphosphatase-1, a gluconeogenesis regulatory enzyme, catalyzes the hydrolysis of fructose 1,6-bisphosphate to fructose 6-phosphate and inorganic phosphate. The mechanism that it functions to antagonize glycolysis and was epigenetically inactivated through NF-kappaB pathway in ga... Full description

Journal Title: PLoS ONE 2011, Vol.6(10), p.e25564
Main Author: Chen, Mingquan
Other Authors: Zhang, Jianbin , Li, Ning , Qian, Zhiping , Zhu, Mengqi , Li, Qian , Zheng, Jianming , Wang, Xinyu , Shi, Guangfeng
Format: Electronic Article Electronic Article
Language: English
Subjects:
ID: E-ISSN: 1932-6203 ; DOI: 10.1371/journal.pone.0025564
Zum Text:
SendSend as email Add to Book BagAdd to Book Bag
Staff View
recordid: plos10.1371/journal.pone.0025564
title: Promoter Hypermethylation Mediated Downregulation of FBP1 in Human Hepatocellular Carcinoma and Colon Cancer (FBP1 Promoter Methylation in HCC and Colon Cancer)
format: Article
creator:
  • Chen, Mingquan
  • Zhang, Jianbin
  • Li, Ning
  • Qian, Zhiping
  • Zhu, Mengqi
  • Li, Qian
  • Zheng, Jianming
  • Wang, Xinyu
  • Shi, Guangfeng
subjects:
  • Research Article
  • Biology
  • Medicine
  • Physics
  • Genetics And Genomics
  • Molecular Biology
  • Oncology
  • Biophysics
  • Physics
  • Gastroenterology And Hepatology
  • Biochemistry
ispartof: PLoS ONE, 2011, Vol.6(10), p.e25564
description: FBP1, fructose-1,6-bisphosphatase-1, a gluconeogenesis regulatory enzyme, catalyzes the hydrolysis of fructose 1,6-bisphosphate to fructose 6-phosphate and inorganic phosphate. The mechanism that it functions to antagonize glycolysis and was epigenetically inactivated through NF-kappaB pathway in gastric cancer has been reported. However, its role in the liver carcinogenesis still remains unknown. Here, we investigated the expression and DNA methylation of FBP1 in primary HCC and colon tumor. FBP1 was lowly expressed in 80% (8/10) human hepatocellular carcinoma, 66.7% (6/9) liver cancer cell lines and 100% (6/6) colon cancer cell lines, but was higher in paired adjacent non-tumor tissues and immortalized normal cell lines, which was well correlated with its promoter methylation status. Methylation was further detected in primary HCCs, gastric and colon tumor tissues, but none or occasionally in paired adjacent non-tumor tissues. Detailed methylation analysis of 29 CpG sites at a 327-bp promoter region by bisulfite genomic sequencing confirmed its methylation. FBP1 silencing could be reversed by chemical demethylation treatment with 5-aza-2′-deoxycytidine (Aza), indicating direct epigenetic silencing. Restoring FBP1 expression in low expressed cells significantly inhibited cell growth and colony formation ability through the induction of G2-M phase cell cycle arrest. Moreover, the observed effects coincided with an increase in reactive oxygen species (ROS) generation. In summary, epigenetic inactivation of FBP1 is also common in human liver and colon cancer. FBP1 appears to be a functional tumor suppressor involved in the liver and colon carcinogenesis.
language: eng
source:
identifier: E-ISSN: 1932-6203 ; DOI: 10.1371/journal.pone.0025564
fulltext: fulltext
issn:
  • 1932-6203
  • 19326203
url: Link


@attributes
ID874704967
RANK0.07
NO1
SEARCH_ENGINEprimo_central_multiple_fe
SEARCH_ENGINE_TYPEPrimo Central Search Engine
LOCALfalse
PrimoNMBib
record
control
sourcerecordid10.1371/journal.pone.0025564
sourceidplos
recordidTN_plos10.1371/journal.pone.0025564
sourcesystemOther
pqid901306542
galeid476867465
display
typearticle
titlePromoter Hypermethylation Mediated Downregulation of FBP1 in Human Hepatocellular Carcinoma and Colon Cancer (FBP1 Promoter Methylation in HCC and Colon Cancer)
creatorChen, Mingquan ; Zhang, Jianbin ; Li, Ning ; Qian, Zhiping ; Zhu, Mengqi ; Li, Qian ; Zheng, Jianming ; Wang, Xinyu ; Shi, Guangfeng
contributorGuan, Xin-yuan (Editor)
ispartofPLoS ONE, 2011, Vol.6(10), p.e25564
identifierE-ISSN: 1932-6203 ; DOI: 10.1371/journal.pone.0025564
subjectResearch Article ; Biology ; Medicine ; Physics ; Genetics And Genomics ; Molecular Biology ; Oncology ; Biophysics ; Physics ; Gastroenterology And Hepatology ; Biochemistry
descriptionFBP1, fructose-1,6-bisphosphatase-1, a gluconeogenesis regulatory enzyme, catalyzes the hydrolysis of fructose 1,6-bisphosphate to fructose 6-phosphate and inorganic phosphate. The mechanism that it functions to antagonize glycolysis and was epigenetically inactivated through NF-kappaB pathway in gastric cancer has been reported. However, its role in the liver carcinogenesis still remains unknown. Here, we investigated the expression and DNA methylation of FBP1 in primary HCC and colon tumor. FBP1 was lowly expressed in 80% (8/10) human hepatocellular carcinoma, 66.7% (6/9) liver cancer cell lines and 100% (6/6) colon cancer cell lines, but was higher in paired adjacent non-tumor tissues and immortalized normal cell lines, which was well correlated with its promoter methylation status. Methylation was further detected in primary HCCs, gastric and colon tumor tissues, but none or occasionally in paired adjacent non-tumor tissues. Detailed methylation analysis of 29 CpG sites at a 327-bp promoter region by bisulfite genomic sequencing confirmed its methylation. FBP1 silencing could be reversed by chemical demethylation treatment with 5-aza-2′-deoxycytidine (Aza), indicating direct epigenetic silencing. Restoring FBP1 expression in low expressed cells significantly inhibited cell growth and colony formation ability through the induction of G2-M phase cell cycle arrest. Moreover, the observed effects coincided with an increase in reactive oxygen species (ROS) generation. In summary, epigenetic inactivation of FBP1 is also common in human liver and colon cancer. FBP1 appears to be a functional tumor suppressor involved in the liver and colon carcinogenesis.
languageeng
source
version9
lds50peer_reviewed
links
openurl$$Topenurl_article
openurlfulltext$$Topenurlfull_article
search
creatorcontrib
0Chen, Mingquan
1Zhang, Jianbin
2Li, Ning
3Qian, Zhiping
4Zhu, Mengqi
5Li, Qian
6Zheng, Jianming
7Wang, Xinyu
8Shi, Guangfeng
9Guan, Xin-yuan (Editor)
titlePromoter Hypermethylation Mediated Downregulation of FBP1 in Human Hepatocellular Carcinoma and Colon Cancer (FBP1 Promoter Methylation in HCC and Colon Cancer)
descriptionFBP1, fructose-1,6-bisphosphatase-1, a gluconeogenesis regulatory enzyme, catalyzes the hydrolysis of fructose 1,6-bisphosphate to fructose 6-phosphate and inorganic phosphate. The mechanism that it functions to antagonize glycolysis and was epigenetically inactivated through NF-kappaB pathway in gastric cancer has been reported. However, its role in the liver carcinogenesis still remains unknown. Here, we investigated the expression and DNA methylation of FBP1 in primary HCC and colon tumor. FBP1 was lowly expressed in 80% (8/10) human hepatocellular carcinoma, 66.7% (6/9) liver cancer cell lines and 100% (6/6) colon cancer cell lines, but was higher in paired adjacent non-tumor tissues and immortalized normal cell lines, which was well correlated with its promoter methylation status. Methylation was further detected in primary HCCs, gastric and colon tumor tissues, but none or occasionally in paired adjacent non-tumor tissues. Detailed methylation analysis of 29 CpG sites at a 327-bp promoter region by bisulfite genomic sequencing confirmed its methylation. FBP1 silencing could be reversed by chemical demethylation treatment with 5-aza-2′-deoxycytidine (Aza), indicating direct epigenetic silencing. Restoring FBP1 expression in low expressed cells significantly inhibited cell growth and colony formation ability through the induction of G2-M phase cell cycle arrest. Moreover, the observed effects coincided with an increase in reactive oxygen species (ROS) generation. In summary, epigenetic inactivation of FBP1 is also common in human liver and colon cancer. FBP1 appears to be a functional tumor suppressor involved in the liver and colon carcinogenesis.
subject
0Research Article
1Biology
2Medicine
3Physics
4Genetics And Genomics
5Molecular Biology
6Oncology
7Biophysics
8Gastroenterology And Hepatology
9Biochemistry
general
010.1371/journal.pone.0025564
1English
sourceidplos
recordidplos10.1371/journal.pone.0025564
issn
01932-6203
119326203
rsrctypearticle
creationdate2011
recordtypearticle
addtitle
0PLoS ONE
1FBP1 Promoter Methylation in HCC and Colon Cancer
searchscopeplos
scopeplos
lsr30VSR-Enriched:[pqid, galeid]
sort
titlePromoter Hypermethylation Mediated Downregulation of FBP1 in Human Hepatocellular Carcinoma and Colon Cancer (FBP1 Promoter Methylation in HCC and Colon Cancer)
authorChen, Mingquan ; Zhang, Jianbin ; Li, Ning ; Qian, Zhiping ; Zhu, Mengqi ; Li, Qian ; Zheng, Jianming ; Wang, Xinyu ; Shi, Guangfeng
creationdate20111019
facets
frbrgroupid8673040863941098178
frbrtype5
languageeng
creationdate2011
topic
0Research Article
1Biology
2Medicine
3Physics
4Genetics And Genomics
5Molecular Biology
6Oncology
7Biophysics
8Gastroenterology And Hepatology
9Biochemistry
collectionPLoS
prefilterarticles
rsrctypearticles
creatorcontrib
0Chen, Mingquan
1Zhang, Jianbin
2Li, Ning
3Qian, Zhiping
4Zhu, Mengqi
5Li, Qian
6Zheng, Jianming
7Wang, Xinyu
8Shi, Guangfeng
9Guan, Xin-yuan
jtitlePLoS ONE
toplevelpeer_reviewed
frbr
t2
k12011
k219326203
k310.1371/journal.pone.0025564
k46
k510
k625564
k7plos one
k8promoter hypermethylation mediated downregulation of fbp1 in human hepatocellular carcinoma colon cancer
k9promoterhypermethylaancer
k12promoterhypermethylationm
k15mingquanchen
k16chenmingquan
delivery
delcategoryRemote Search Resource
fulltextfulltext
ranking
booster11
booster21
pcg_typepublisher
addata
aulast
0Chen
1Zhang
2Li
3Qian
4Zhu
5Zheng
6Wang
7Shi
8Guan
aufirst
0Mingquan
1Jianbin
2Ning
3Zhiping
4Mengqi
5Qian
6Jianming
7Xinyu
8Guangfeng
9Xin-yuan
au
0Chen, Mingquan
1Zhang, Jianbin
2Li, Ning
3Qian, Zhiping
4Zhu, Mengqi
5Li, Qian
6Zheng, Jianming
7Wang, Xinyu
8Shi, Guangfeng
addauGuan, Xin-yuan
atitlePromoter Hypermethylation Mediated Downregulation of FBP1 in Human Hepatocellular Carcinoma and Colon Cancer (FBP1 Promoter Methylation in HCC and Colon Cancer)
jtitlePLoS ONE
risdate20111019
volume6
issue10
spagee25564
pagese25564
eissn1932-6203
genrearticle
ristypeJOUR
abstractFBP1, fructose-1,6-bisphosphatase-1, a gluconeogenesis regulatory enzyme, catalyzes the hydrolysis of fructose 1,6-bisphosphate to fructose 6-phosphate and inorganic phosphate. The mechanism that it functions to antagonize glycolysis and was epigenetically inactivated through NF-kappaB pathway in gastric cancer has been reported. However, its role in the liver carcinogenesis still remains unknown. Here, we investigated the expression and DNA methylation of FBP1 in primary HCC and colon tumor. FBP1 was lowly expressed in 80% (8/10) human hepatocellular carcinoma, 66.7% (6/9) liver cancer cell lines and 100% (6/6) colon cancer cell lines, but was higher in paired adjacent non-tumor tissues and immortalized normal cell lines, which was well correlated with its promoter methylation status. Methylation was further detected in primary HCCs, gastric and colon tumor tissues, but none or occasionally in paired adjacent non-tumor tissues. Detailed methylation analysis of 29 CpG sites at a 327-bp promoter region by bisulfite genomic sequencing confirmed its methylation. FBP1 silencing could be reversed by chemical demethylation treatment with 5-aza-2′-deoxycytidine (Aza), indicating direct epigenetic silencing. Restoring FBP1 expression in low expressed cells significantly inhibited cell growth and colony formation ability through the induction of G2-M phase cell cycle arrest. Moreover, the observed effects coincided with an increase in reactive oxygen species (ROS) generation. In summary, epigenetic inactivation of FBP1 is also common in human liver and colon cancer. FBP1 appears to be a functional tumor suppressor involved in the liver and colon carcinogenesis.
copSan Francisco, USA
pubPublic Library of Science
doi10.1371/journal.pone.0025564
oafree_for_read
date2011-10-19